Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of three bowel cleansing medicines for total colonoscopy
2012-003958-82Phase 4Active
- Sponsor
- Istituto Oncologico Veneto
- Start
- Oct 2012
- Modality
- Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Non-biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, randomised trial of macrogol 4000, bisacodyl and polyethylene glycol 3350 in colorectal cancer (CRC) and gastrointestinal conditions (3 arms), sponsored by Istituto Oncologico Veneto. Primary endpoint: Bowel cleansing efficacy. Started Oct 2012; status: active.
02
Drugs
macrogol 4000bisacodylpolyethylene glycol 3350
03
Conditions
colorectal cancer (CRC)gastrointestinal conditions
Beyond the preview
Go deeper on 2012-003958-82.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-003958-82.